Degenerative Neurological Diseases Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Degenerative Diseases

Overview

A

Diseases of gray matter characterized principally by the progressive loss of neurons with associated secondary changes in white matter tracts.

  • Common pathologic process seen in many of these ⇒ accumulation of protein aggregates
  • Two other general characteristics:
    1. Pattern of neuronal loss is selective, affecting one or more groups of neurons while leaving others intact
    2. Diseases arise without any clear inciting event in patients without previous neurologic deficits
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Degenerative Disease

Locations

A
  • Cerebral Cortex
    • Alzheimer
    • Fronto Temporal Lobar Degenerations (FTLD)
      • Includes Pick Disease
    • Vascular Dementia
  • Basal Ganglia
    • Parkinson
    • Huntington
  • Motor Neurons
    • ALS and similar diseases (adults)
    • Werdnig Hoffman Disease (children)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Dementia

Definition

A

“Degenerative Cortical Disease”

Syndrome comprising “global” impairment of higher cortical functions in the absence of gross clouding of consciousness.

Affects memory, capacity to solve problems of everyday living, performance of learned perceptual (motor skills, correct social skills), and control of emotional reactions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Dementia

Etiologies

A
  • Degenerative diseases
  • Chronic Infections
  • Vitamin Deficiencies
  • Toxins
  • Diffuse Brain Injury
  • Metabolic Disorders
  • Mass Lesions
  • Genetic Diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Alzheimer Disease

Overview

A

“Senile Dementia of Alzheimer’s Type –SDAT”

  • Most common cause of dementia in the elderly
    • Rarely symptomatic before age 50
    • Incidence rises with age:
      • 1% of 60-65 y/o
      • 40% of 85-89 y/o
  • 5-10% of cases are familial
  • Examination of brain tissue is necessary for definitive diagnosis
  • Clinical and radiographic assessment is 80-90% accurate
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Alzheimer

Gross Findings

A
  • Variable degree of cortical atrophy
  • Widening of the cerebral sulci most pronounced in frontal, temporal, and parietal lobes
  • Significant atrophy ⇒ compensatory ventricular enlargement (hydrocephalus ex vacuo) secondary to loss of parenchyma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Alzheimer

Molecular Genetics and Pathogenesis

A
  • Accumulation of Amyloid β (Aβ) and tau proteins in specific brain regions
    • Likely d/t excessive production and defective removal
  • Plaques ⇒ Deposits of aggregated Aβ peptides in neuropil
  • Tangles ⇒ Aggregates of the microtubule binding protein tau
    • Develop intracellularly and then persist extracellularly after neuronal death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Alzheimer Disease

Histological Changes

A
  • Changes can be found in brains of elderly nondemented individuals
  • Alzheimer disease dx is based on clinical and pathologic features
  • Changes are most severe in certain regions particularly the hippocampal pyramidal cell layer
  • Cannot see these changes using H and E, need special silver stains to see the senile plaques and neurofibrillary tangles
  • Findings associated with severe loss of neurons in the brain and loss of brain tissue ⇒ seen as cerebral atrophy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Alzheimer Disease

Histological Features

A
  • Neuritic (senile) plaques
    • Extracellular accumulations of organelles and amyloid protein
  • Neurofibrillary tangles
    • Intracellular accumulation of organelles, neurofilaments, and microtubular proteins
    • Become extracellular after death of neuron
  • Cerebral amyloid angiopathy (CAA)
    • Vascular amyloid is predominantly Aβ40
    • Also true when CAA occurs without AD
  • Granulovacuolar degeneration
    • Formation of small clear intraneuronal cytoplasmic vacuoles
    • Each contains an argyrophilic granule
    • Seen in great abundance in hippocampus and olfactory bulb in Alzheimer disease
  • Hirano bodies
    • Elongated, glassy, eosinophilic bodies
    • Contains paracrystalline arrays of beaded filaments w/ actin as their major component
    • Found most commonly within hippocampal pyramidal cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alzheimer Disease

Clinical Features

A
  • Entorhinal cortex ⇒ direction loss [spatial] (Major hippocampal input)
  • Hippocampus ⇒ memory loss
  • Neocortex ⇒ loss of higher cortical functions

Degree of dementia correlates better with neurofibrillary tangles and loss of synapses than with neuritic plaques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Alzheimer Disease

Genetic Predisposition

A
  • Small number of families transmit early-onset AD as a dominant genetic trait
  • Also see form of AD in adults with Down Syndrome
  • Both show over-representation of genes on Chromosome 21 ⇒ coding for cerebral amyloid
    • Unclear relevance in sporadic AD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Frontotemporal Lobar Degenerations

(FTLD)

A
  • Heterogeneous set of disorders
  • See focal degeneration of frontal and/or temporal lobes
  • Alterations in personality, behavior, and language (aphasias) precede memory loss
  • Divided into two groups by what is in the cellular inclusions:
    • FTLD-tau
    • FTLD-TDP
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

FTLD-tau

A
  • Affected regions show neuronal loss and reactive gliosis
  • Tau-containing inclusions in neuron cytoplasm
  • Inclusions can take form of tangles or smooth contoured inclusions (Pick bodies)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Pick Disease

A
  • Type of FTLD-tau
  • Gyral atrophy
    • Relatively confined to anterior portion of frontal lobes and lower portions of temporal lobes
    • Superior gyrus, parietal and occipital lobes spared
    • More severe than in Alzheimer’s ⇒ ‘knife edge cortex
  • Pick Bodies
    • Spherical neuronal inclusions ⇒ push nucleus to one side
    • Made of neurofilaments (tau)
    • Stains positively for silver
    • Do not persist after neuronal death
  • Early-onset behavioral changes (rare):
    • Alterations in personality [Frontal Lobe]
    • Language disturbances [Temporal Lobe]
  • Most cases are sporadic
  • Few familial forms linked to mutations in tau
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Vascular Dementia

A
  • Vascular injury can cause dementia
  • Treatment of vasculitis will cause cognitive improvement
  • Etiologies:
    • Hypoperfusion ⇒ multiple small infarcts, cortical laminar necrosis
    • Chronic HTN ⇒ diffuse white matter injury (Binswanger disease)
    • Embolism ⇒ strategic infarcts to hippocampus, DM thalamus or frontal cortex
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Lacunar Infarcts

A
  • Seen only in the nervous system
  • Occurs in deep penetrating arteries and arterioles supplying:
    • Basal ganglia
    • Hemispheric white matter
    • Brainstem
  • Chronic untreated HTN ⇒ arteriolar sclerosis and occlusion
  • Results in single or multiple, small, cavitary infarctslacunes (lacunar infarcts)
  • Tiny cystic (lake-like spaces) occur in: lenticular nucleus > thalamus > internal capsule > deep white matter > caudate nucleus > pons
  • Microscopic appearance: cavities due to lost tissue with scattered fat-laden and surrounding gliosis
  • Depending on location ⇒ clinically silent or cause severe neurologic impairment (can see a Parkinson’s-like syndrome)
17
Q

Multi-Infarct Dementia

A
  • Patients suffer multiple, bilateral, gray matter (cortex, thalamus, basal ganglia) and white matter (centrum semiovale) infarcts over a period of time
  • Develop a distinctive clinical syndrome (vascular/multi-infarct dementia)
  • Characterized by dementia, gait abnormalities, and pseudobulbar signs, often with superimposed focal neurologic deficits
  • Can see multifocal vascular disease in patients with:
    • Cerebral atherosclerosis
    • Vessel thrombosis or embolization from carotid vessels or from the heart
    • Cerebral arteriolar sclerosis from chronic HTN
18
Q

Parkinson Disease

Overview

A
  • Tends to develop in middle to late life
  • Most cases are sporadic, but there are inherited cases (autosomal dominant)
  • Clinical features: decreased facial expression, stooped posture, slowed voluntary movement, shortened accelerated steps, rigidity, pill-rolling tremor
  • Gross findings: pallor of the substantia nigra and locus ceruleus
19
Q

Parkinson Disease

Histology

A
  • Loss of the pigmented, catecholaminergic neurons in basal ganglia associated with gliosis
  • ± Lewy bodies in remaining neurons
  • Single or multiple, cytoplasmic, eosinophilic, round to elongated inclusions that often have a dense core surrounded by a pale halo
  • Composed of fine filaments, densely packed in the core but loose at the rim
20
Q

Parkinson Disease

Pathogenesis and Treatment

A
  • Pigmented neurons of substantia nigra synthesize dopamine and project to basal ganglia
  • These neurons die ⇒ dopaminergic input to basal ganglia ⇒ Parkinson symptoms
    • MPTP (1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine) ⇒ drug that caused degeneration of substantia nigra and Parkinson’s symptoms provided animal model to study
  • L-DOPA (crosses BBB): symptomatic relief but does not arrest progress or reverse morphologic changes
  • Neural transplantation, brain stimulation used in treatment today
21
Q

Parkinsonism

A

Clinical syndrome caused by damage to the nigrostriatal dopaminergic system can have several etiologies:

  • Parkinson Disease
  • Multiple System Atrophy
  • Post-encephalitis (1914-1918 Influenza epidemic)
  • Toxins (pesticides)
  • Drugs (MPTP)
22
Q

Parkinson Disease

Molecular Genetics

A

Genes found in familial forms of PD:

  • a-synuclein ⇒ lipid-binding protein in synapses
    • Basis of autosomal dominant PD
    • Major component of Lewy Bodies
    • Likely dosage dependent (3X)
  • Parkin ⇒ E3 Ubiquitin ligase
    • Involved in mitochondrial dysfunction
  • UCH-L1 ⇒ (De)ubiquitination enzyme
    • Decrease function mutations
    • Link through all of these is protein accumulation/altered degradation
23
Q

Dementia with Lewy Bodies

A
  • 10-15% of Parkinson Disease patients develop dementia
  • Some of these are probably AD
  • Others show many Lewy bodies in neurons of cortex and brainstem
  • Probably represents advanced stage of PD
24
Q

Atypical Parkinsonism Syndromes

A

See clinical syndrome of parkinsonism but don’t respond to L-DOPA and also see other signs and symptoms

  • Tauopathies
    • Progressive Supranuclear Palsy (PSP)
    • Corticobasal Degeneration (CBD)
  • Synucleinopathy
    • Multisystem Atrophy
25
Q

Huntington Disease

Overview

A
  • Progressive movement disorder and dementia
    • Jerky, hyperkinetic, dystonic movements
  • Usually symptomatic at 30-50 y/o
  • Disease is fatal within several years
  • Autosomal Dominant:
    • HTT gene is on Chromosome 4p16.3
    • Codes for a protein called Huntingtin
    • First exon has stretch of CAG repeats encodes polyglutamine region near N terminus of protein
    • Function of the protein is unknown
    • Genetic testing is available
26
Q

Huntington Disease

Pathogenesis

A
  • Striatal neurons are lost and fibrillary gliosis is extensive
  • Loss of striatal output ⇒ ⊗ subthalamic nucleus ⇒ dysregulation of motor activity and choreoathetosis (early)
  • Neuronal loss from the cerebral cortex correlates with cognitive changes and dementia (later)
27
Q

HTT Genes

A
  • Contain 6-35 copies of the repeat
    • See pathology above this level
    • Inverse relationship between repeat number and age of onset
    • Longer repeats usually associated with earlier onset
  • But another factor is that paternal transmission is associated with early onset in the next generation because expansions occur during spermatogenesis ⇒ anticipation
  • In contrast to many of the other degenerative diseases, there is no sporadic form of HD
28
Q

Degenerative Diseases of Motor Neurons

(Adults)

A
  • Amyotrophic Lateral Sclerosis
    • Affects anterior horn cells and corticospinal tracts
    • Results in muscle wasting and spastic paralysis
  • Progressive Muscular Atrophy
    • Affects anterior horn cells see flaccid paralysis and muscle wasting
  • Primary Lateral Sclerosis
    • Affects corticospinal tract, spasticity dominant
  • Progressive Bulbar Palsy
    • Lower brainstem cranial motor nuclei (V, VII, IX, and XII)
29
Q

Amyotrophic Lateral Sclerosis (ALS)

Overview

A

“Lou Gehrig’s Disease”

  • Neurogenic muscular atrophy due to the loss of lower motor neurons (anterior horn cells)
  • Hyperflexia and Babinski sign due to loss of upper motor neurons (Betz cells) that project in corticospinal tracts
  • Sensory and cognitive functions are unaffected
  • Usually presents after 40 y/o
  • 5-10% are familial (AD)
30
Q

Amyotrophic Lateral Sclerosis

Clinical Features

A
  • Early: Asymmetric hand weakness, cramping and spasticity of arms and legs
  • Then: Decreased muscle strength and mass; and fasciculations (motor unit contractions)
  • Eventually: Respiratory muscles affected; recurrent bouts of pneumonia
  • Death usually occurs in 5-10 years
  • Spinal Cord: demyelination in corticospinal tracts and atrophy of anterior nerve roots
31
Q

Werdnig-Hoffman Disease

A
  • Motor neuron disease of infants, usually symptomatic at birth
  • Poor suck, weak cry, little movement of arms or legs
  • Differential diagnosis is some type of primary muscle disease
  • Some cases seem sporadic, others genetically determined as either recessive or autosomal traits
  • Pathology: changes similar to those found in adult motor neuron disease
  • Children usually die during first few years of life